On ECHEMI
Home > Drugs > Gastric cancer
Gastric cancer
Gastric cancer is one of the most common malignant tumors in my country. Its incidence rate ranks first among digestive tract tumors in my country. About 170,000 people die from gastric cancer every year. It is a disease that seriously threatens people's health. Gastric cancer can occur at any age, but it is more common in people aged 40 to 60. Males are more likely to be diagnosed than females, with a ratio of about 3:1. Cancer can occur in any part of the stomach, but it is more common in the gastric antrum, especially the lesser curvature of the stomach. The average life expectancy of untreated patients is about 13 months.
Related Drugs
Fluorouracil
Indication: It is clinically used for colon cancer, rectal cancer, gastric cancer, breast cancer, ovarian cancer, choriocarcinoma, malignant hydatidiform mole, head and neck squamous cell carcinoma, skin cancer, liver cancer, bladder cancer, etc.
Manufacturer:

Nantong Jinghua Pharmaceutical Co., Ltd.

Fluorouracil
Indication: It is clinically used for colon cancer, rectal cancer, gastric cancer, breast cancer, ovarian cancer, choriocarcinoma, malignant hydatidiform mole, head and neck squamous cell carcinoma, skin cancer, liver cancer, bladder cancer, etc.
Manufacturer:

Bei Jing Scrianen Pharmaceutical Co., Ltd.

Fluorouracil
Indication: It is clinically used for colon cancer, rectal cancer, gastric cancer, breast cancer, ovarian cancer, choriocarcinoma, malignant hydatidiform mole, head and neck squamous cell carcinoma, skin cancer, liver cancer, bladder cancer, etc.
Fluorouracil
Indication: It is clinically used for colon cancer, rectal cancer, gastric cancer, breast cancer, ovarian cancer, choriocarcinoma, malignant hydatidiform mole, head and neck squamous cell carcinoma, skin cancer, liver cancer, bladder cancer, etc.
Manufacturer:

Shanghai Xudong Haipu Nantong Pharmaceutical Co., Ltd.

Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:

Jilin Yimintang Pharmaceutical Co., Ltd.

Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:

Hainan General Alliance Pharmaceutical Co., Ltd.

Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:

Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co., Ltd.

Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:

Shandong Ruiying Pioneer Pharmaceutical Co., Ltd.

Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.